A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight -- without causing nausea.

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

Justin Menchaca, a former Army Sergeant First Class, has embarked on a remarkable journey of recovery after being shot in the ...